P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease*

Primary rat microglia stimulated with either ATP or 2′- and 3′-O-(4-benzoylbenzoyl)-ATP (BzATP) release copious amounts of superoxide (O 2 ⨪ ). ATP and BzATP stimulate O 2 ⨪ production through purinergic receptors, primarily the P2X7 receptor. O 2 ⨪ is produced through the activation of the NADPH oxidase. Although both p42/44 MAPK and p38 MAPK were activated rapidly in cells stimulated with BzATP, only pharmacological inhibition of p38 MAPK attenuated O 2 ⨪ production. Furthermore, an inhibitor of phosphatidylinositol 3-kinase attenuated O 2 ⨪ production to a greater extent than an inhibitor of p38 MAPK. Both ATP and BzATP stimulated microglia-induced cortical cell death indicating this pathway may contribute to neurodegeneration. Consistent with this hypothesis, P2X7 receptor was specifically up-regulated around β-amyloid plaques in a mouse model of Alzheimer's disease (Tg2576).

• Publication year

  2003

• Venue

  Journal of Biological Chemistry

• Publication date

  2003-04-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/JBC.M209478200PMID 12551918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extracellular ATP and P2X7 receptors in neurodegeneration.

  2002cited by this paper
• Cytosolic Phospholipase A2 (cPLA2) Regulation of Human Monocyte NADPH Oxidase Activity

  2002cited by this paper
• In-vivo measurement of activated microglia in dementia.

  2001cited by this paper
• beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.

  2001cited by this paper
• β-Amyloid Stimulation of Microglia and Monocytes Results in TNFα-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis

  2001cited by this paper
• Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity

  2001cited by this paper
• PtdIns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40phox

  2001cited by this paper
• The PX domains of p47phox and p40phox bind to lipid products of PI(3)K

  2001cited by this paper
• Extracellular ATP or ADP Induce Chemotaxis of Cultured Microglia through Gi/o-Coupled P2Y Receptors

  2001cited by this paper
• ATP Mediates Calcium Signaling Between Astrocytes and Microglial Cells: Modulation by IFN-γ1

  2001cited by this paper
• Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

  2001cited by this paper
• cAMP delays beta‐amyloid (25‐35) induced cell death in rat cortical neurons

  2000cited by this paper
• Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells.

  2000cited by this paper
• ATP as a presynaptic modulator.

  2000cited by this paper
• Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia.

  2000cited by this paper
• Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195

  2000cited by this paper
• Extracellular ATP Triggers Tumor Necrosis Factor‐α Release from Rat Microglia

  2000cited by this paper
• Activation of purinergic P2X receptors inhibits P2Y-mediated Ca2+ influx in human microglia.

  2000cited by this paper
• Kinetics and Mechanism of ATP-Dependent IL-1β Release from Microglial Cells1

  2000cited by this paper
• Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors.

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells

  2000cited by this paper
• The Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway Is Involved in formyl-Methionyl-Leucyl-Phenylalanine-Induced p47phox Phosphorylation in Human Neutrophils1

  2000cited by this paper
• Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs).

  1999cited by this paper
• Two different ionotropic receptors are activated by ATP in rat microglia

  1999cited by this paper
• P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death

  1999cited by this paper
• Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38.

  1999cited by this paper
• beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease.

  1999cited by this paper
• Stimulation of a Vascular Smooth Muscle Cell NAD(P)H Oxidase by Thrombin

  1999cited by this paper
• Modulation of P2X7 nucleotide receptor expression by pro‐ and anti‐inflammatory stimuli in THP‐1 monocytes

  1998cited by this paper
• Type I cAMP-dependent Protein Kinase Delays Apoptosis in Human Neutrophils at a Site Upstream of Caspase-3*

  1998cited by this paper
• Long-term activation of capacitative Ca2+ entry in mouse microglial cells.

  1998cited by this paper
• Blockade of human P2X7 receptor function with a monoclonal antibody

  1998cited by this paper
• Blockade of human P2X7 receptor function with a monoclonal antibody.

  1998cited by this paper
• Inhibition of NADPH Oxidase Activation by 4-(2-Aminoethyl)-benzenesulfonyl Fluoride and Related Compounds*

  1997cited by this paper
• ATP-mediated cytotoxicity in microglial cells.

  1997cited by this paper
• Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA)

  1997cited by this paper
• Coexistence of purino‐ and pyrimidinoceptors on activated rat microglial cells

  1997cited by this paper
• A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative.

  1997cited by this paper
• Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase.

  1997cited by this paper
• Amyloid Fibrils Activate Tyrosine Kinase-Dependent Signaling and Superoxide Production in Microglia

  1997cited by this paper
• Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line.

  1996cited by this paper
• Mouse microglial cells express a plasma membrane pore gated by extracellular ATP.

  1996cited by this paper
• Endogenous nitric oxide activates prostaglandin F2 alpha production in human microglial cells but not in astrocytes: a study of interactions between eicosanoids, nitric oxide, and superoxide anion (O2-) regulatory pathways.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Chemoattractant signaling and leukocyte activation.

  1995cited by this paper
• Cytokine modulation of murine microglial cell superoxide production

  1995cited by this paper
• Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol.

  1994cited by this paper
• Characterization and possible function of adenosine 5′‐triphosphate receptors in activated rat microglia

  1994cited by this paper
• Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes.

  1994cited by this paper
• Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor.

  1993cited by this paper
• Expression of the pore-forming P2Z purinoreceptor in Xenopus oocytes injected with poly(A)+ RNA from murine macrophages.

  1993cited by this paper
• Electrophysiological behavior of microglia

  1993cited by this paper
• A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages.

  1992cited by this paper
• [46] Measurement of O2− secreted by monocytes and macrophages

  1984cited by this paper
• Measurement of O2- secreted by monocytes and macrophages.

  1984cited by this paper
• Cell Calcium

  year unknowncited by this paper

• P2X7 receptors as targets for neuroprotection.

  2026cites this paper
• The NLRP3-P2X7 Axis and Cytokine Crosstalk in Alzheimer's Disease: Mechanisms, Implications, and Therapeutic Opportunities.

  2025cites this paper
• The Taming of the Shrew: Making Microglia Neuroprotective by Inhibiting Cx43 Hemichannels

  2025cites this paper
• Extracellular nucleotides mediate viral central nervous system infections: Key alarmins of neuroinflammation and neurodegeneration

  2025cites this paper
• The Multifaceted Role of P2X7R in Microglia and Astrocytes

  2025cites this paper
• P2X receptors in GtoPdb v.2025.3

  2025cites this paper
• Unveiling the P2X7 receptor: Exploring its mechanisms, pathogenic role in ocular diseases, and emerging therapeutic potential.

  2025cites this paper
• Inhibition of P2X7R Activation Ameliorates Damage to the Corneas and Corneal Nerves of Rats with Streptozotocin (STZ)-Induced Type 1 Diabetes

  2025cites this paper
• P2RX7 Dynamics in CNS Disorders: Molecular Insights and Therapeutic Perspectives

  2025cites this paper
• Astrocytic Connexin43 in Alzheimer's disease: mechanisms, interaction with P2 receptors, and therapeutic potential.

  2025cites this paper
• Role of Ion Channels in Alzheimer’s Disease Pathophysiology

  2025cites this paper
• Targeting Microglial Connexin43 Hemichannels: A Novel Therapeutic Avenue for Alzheimer’s Disease

  2025cites this paper
• Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human

  2024influential citation
• Comorbidity Genes of Alzheimer’s Disease and Type 2 Diabetes Associated with Memory and Cognitive Function

  2024cites this paper
• Selenoprotein P is a target for regulating extracellular vesicle biogenesis and secretion from activated microglia in vivo

  2024cites this paper
• Microglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges

  2024cites this paper
• Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA

  2024cites this paper
• ATP-P2X7 signaling mediates brain pathology while contributing to viral control in perinatal Zika virus infection.

  2024cites this paper
• NOX2 in Alzheimer's and Parkinson's disease

  2024cites this paper
• Purinergic receptor P2X7 regulates interleukin-1α mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner.

  2024cites this paper
• Transcriptomic alterations in APP/PS1 mice astrocytes lead to early postnatal axon initial segment structural changes

  2024cites this paper
• Targeting blood-brain barrier for sepsis-associated encephalopathy: Regulation of immune cells and ncRNAs.

  2024cites this paper
• Purinergic-associated immune responses in neurodegenerative diseases.

  2024cites this paper
• P2 purinergic receptor expression and function in tumor-related immune cells

  2024cites this paper
• Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders

  2024cites this paper
• P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

  2023cites this paper
• Role of neuroinflammation in neurodegeneration development

  2023cites this paper
• Microglia as a Game Changer in Epilepsy Comorbid Depression

  2023cites this paper
• Purinergic receptors in cognitive disturbances.

  2023cites this paper
• The P2X7 Receptor, a Multifaceted Receptor in Alzheimer’s Disease

  2023cites this paper
• Insights into Advanced Neurological Dysfunction Mechanisms Following DBS Surgery in Parkinson’s Patients: Neuroinflammation and Pyroptosis

  2023cites this paper
• Recombinant Analogs of Sea Anemone Kunitz-Type Peptides Influence P2X7 Receptor Activity in Neuro-2a Cells

  2023cites this paper
• Aurantiamide suppresses the activation of NLRP3 inflammasome to improve the cognitive function and central inflammation in mice with Alzheimer's disease

  2023cites this paper
• The neuroinflammatory astrocytic P2X7 receptor: Alzheimer’s disease, ischemic brain injury, and epileptic state

  2023cites this paper
• Effects of NADPH Oxidase Isoform-2 (NOX2) Inhibition on Behavioral Responses and Neuroinflammation in a Mouse Model of Neuropathic Pain

  2023cites this paper
• Identification of residues in the first transmembrane domain of the P2X7 that regulates receptor trafficking, sensitization, and dye uptake function

  2023cites this paper
• Inhibition of Galectins and the P2X7 Purinergic Receptor as a Therapeutic Approach in the Neurovascular Inflammation of Diabetic Retinopathy

  2023cites this paper
• Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.

  2023cites this paper
• The NLRP3 Inflammasome in Age-Related Cerebral Small Vessel Disease Manifestations: Untying the Innate Immune Response Connection

  2023cites this paper
• Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease

  2023cites this paper
• Extracellular ATP-induced mitogenic response in rat kidney is mediated via purinergic P2X7Rs

  2023cites this paper
• P2Y receptors in GtoPdb v.2023.1

  2023cites this paper
• Glial Purinergic Signaling-Mediated Oxidative Stress (GPOS) in Neuropsychiatric Disorders

  2022cites this paper
• Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease.

  2022cites this paper
• Dietary consumption of desert olive tree pearls reduces brain Aβ content and improves learning and memory ability in aged mice

  2022cites this paper
• Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease

  2022cites this paper
• Oxidative stress and regeneration.

  2022cites this paper
• The ATP-dependent pathways and human diseases.

  2022cites this paper
• Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer’s Disease in the Context of the COVID-19 Pandemic

  2022cites this paper
• Astrocyte adaptation in Alzheimer’s disease: a focus on astrocytic P2X7R

  2022cites this paper
• Ocular P2 receptors and glaucoma.

  2022cites this paper
• P2X7-dependent immune pathways in retinal diseases.

  2022cites this paper
• P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases

  2022cites this paper
• Determination of miR-373 and miR-204 levels in neuronal exosomes in Alzheimer’s disease

  2022cites this paper
• P2X7 receptor‐mediated release of microglial prostanoids and miRNAs correlates with reversal of neuropathic hypersensitivity in rats

  2022cites this paper
• Platelets and the Role of P2X Receptors in Nociception, Pain, Neuronal Toxicity and Thromboinflammation

  2022cites this paper
• Microglia in Alzheimer’s Disease: An Unprecedented Opportunity as Prospective Drug Target

  2022cites this paper
• PET Imaging of P2X7 Receptor (P2X7R) for Neuroinflammation with Improved Radiosynthesis of Tracer [18F]4A in Mice and Non-human Primates.

  2022cites this paper
• Physiologic roles of P2 receptors in leukocytes

  2022cites this paper
• Profiles and Dynamics of the Transcriptome of Microglial Cells Reveal their Inflammatory Status

  2021cites this paper
• The role of P2X7R in neuroinflammation and implications in Alzheimer's disease.

  2021cites this paper
• PI3Kγ Mediates Microglial Proliferation and Cell Viability via ROS

  2021cites this paper
• P2X7 receptors in the central nervous system.

  2021cites this paper
• P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches

  2021cites this paper
• PET Imaging of Neuroinflammation

  2021cites this paper
• Immunohistochemical evidence of P2X7R, P2X4R and CaMKK2 in pyramidal neurons of frontal cortex does not align with Alzheimer's disease.

  2021cites this paper
• NADPH Oxidases in the Central Nervous System: Regional and Cellular Localization and the Possible Link to Brain Diseases

  2021cites this paper
• P2 × 7 receptor blockade reduces Tau induced toxicity, therapeutic implications in Tauopathies.

  2021cites this paper
• Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review

  2021cites this paper
• Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X7R signaling

  2021cites this paper
• A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease

  2021cites this paper
• Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2

  2021cites this paper
• Purinergic signaling in the modulation of redox biology

  2021cites this paper
• DJ-1 in neurodegenerative diseases: pathogenesis and clinical application.

  2021cites this paper
• Grape skin extract modulates neuronal stem cell proliferation and improves spatial learning in senescence-accelerated prone 8 mice

  2021cites this paper
• Glial Purinergic Signaling in Neurodegeneration

  2021cites this paper
• Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease

  2021cites this paper
• Antagonistic Roles of P2X7 and P2Y2 Receptors in Neurodegenerative Diseases

  2021cites this paper
• From purines to purinergic signalling: molecular functions and human diseases

  2021cites this paper
• Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?

  2021cites this paper
• Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation.

  2021cites this paper
• The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer’s Disease

  2021cites this paper
• P2X7 receptor in multifaceted cellular signaling and its relevance as a potential therapeutic target in different diseases.

  2021cites this paper
• Regulatory function of Pja2 mediated by the P2rx3/P2rx7 axis in mouse hippocampal neuronal cells.

  2020cites this paper
• The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use.

  2020cites this paper
• The Role of NMDA Receptors in the Effect of Purinergic P2X7 Receptor on Spontaneous Seizure Activity in WAG/Rij Rats With Genetic Absence Epilepsy

  2020cites this paper
• Recent Progress on the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-Peptide Aggregation.

  2020cites this paper
• The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view

  2020cites this paper
• Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease

  2020cites this paper
• Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease.

  2020cites this paper
• Neuroinflammation, oxidative stress and their interplay in neuropathic pain: focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies.

  2020cites this paper
• The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease.

  2020cites this paper
• Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.

  2020cites this paper
• The Basis For A Neurobiological-Associative Model of Personality and Group Cohesion: The Evolutionary And System Biological Origins Of Social Exclusion, Hierarchy, and Structure

  2020cites this paper
• P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice

  2020cites this paper
• P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases

  2020cites this paper
• The P2X7 Receptor: Central Hub of Brain Diseases

  2020cites this paper
• P2X7 in Cancer: From Molecular Mechanisms to Therapeutics

  2020cites this paper
• The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases

  2020influential citation
• Purinergic signaling in infectious diseases of the central nervous system

  2020cites this paper